PharmaFox Therapeutics Email Formats

Biotechnology Research • Möhlin, Aargau, Switzerland • 1-10 Employees

Key Contact at PharmaFox Therapeutics

Ruggero Fariello

Co Founder, co Owner

Company overview

Headquarters	Untere Fuchsrainstrasse 16, Möhlin, aargau 4313, CH
Website	pharmafox.ch
NAICS	541714
Founded	2014
Employees	1-10

About PharmaFox Therapeutics

PharmaFox develops innovative compounds until clinical phase 1/2 for the pharmaceutical market. As soon as the early development phase is completed PharmaFox expects interest from Pharma companies. In this case it is foreseen that the assets will be sold. Investing in PharmaFox is a relatively low risk investment and can generate a high upside potential. The innovative pharma approach applied by the founders is already substantially de-risked. The companies lead compound is active in a high profile muscle disease (sarcopenia) making an early sale with an attractive deal probable. The ultimate goal of the investments is to create an optimal and realistic exit opportunity.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

PharmaFox Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

PharmaFox Therapeutics has never raised funding before.

Frequently asked questions

PharmaFox Therapeutics is located in Möhlin, Aargau, CH.

PharmaFox Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

PharmaFox Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at PharmaFox Therapeutics

Ruggero Fariello

Co Founder, co Owner

4.8

40,000 users